INDRAMEDCO share price, P/E, ROE & financials

On 6 Nov 2026, Indraprastha Medical Corporation was priced at ₹330.20, or 16.1× trailing earnings, against an industry P/E of 47.7×, and the shares are 47% below their 52-week high. Its ROCE of 30% is the highest among the 7 largest Medical Care Facilities peers, and sales and net profit grew 10% and 29% a year over 3 years. It has almost no debt, and its dividend yield is 1.2%. It is a small-cap company with a market cap of ₹3,027 Cr, ranked 17th of 40 Medical Care Facilities companies by market cap; the shares fell 45% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹332.80
Day high: ₹332.80
Day low: ₹327.00
Prev. close: ₹333.75
Volume: 78.7K

Health check

3 good · 1 fair · 2 to check

ReturnsBehind
−44.8% over a year, better than 0 of 7 peers.
Price tagCheaper
P/E 16.1 vs industry 47.7.
GrowthSteady
Sales +10.2%, profit +28.7% a year over 3 years.
ProfitabilityStrong
ROCE 30.3% vs peer median 11.9%.
Balance sheetSolid
Practically debt-free, Piotroski 6 of 9.
Red flags1 to check
47% below its 52-week high.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹3,027 Cr, #17 of 40 in its industry by size.

Defensive

Beta 0.51 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹1,555 Cr · profit ₹192 Cr

Market cap: ₹3,027 Cr; Small cap
P/E: 16.1; Industry 47.7
Price to book: 3.72; Peers 8.06
Dividend yield: 1.21%
ROE: 26.1%; Peers 12.8%
ROCE: 30.3%; Peers 11.9%
Debt to equity: 0.04; Debt ₹35 Cr
EPS (TTM): ₹20.51; Face value ₹10
OPM (TTM): 18.3%; Net margin 12.4%
Sales growth: +11.3%; Latest quarter vs a year ago
Profit growth: +8.5%; Latest quarter vs a year ago
Price to sales: 1.95; EV/EBITDA 9.9

Strengths

Return on equity of 26.1%.
Return on capital employed of 30.3%.
Practically debt-free.
P/E of 16.1 against an industry P/E of 47.7.
Positive operating cash flow in each of the last 4 years.

Risks to check

47% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Indraprastha Medical Corporation

Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of genomic medicine, internal medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and…

Headquarters: New Delhi
Employees: 3,000
Sector: Healthcare
ISIN: INE681B01017
Website: apollohospitals.com

Price range

52 weeks

₹293.65₹623.00

Today

₹327.00₹332.80

Avg volume (3M): 2 L
1-year return: minus 44.8%
From 52-week high: minus 47.0%

Peers · Medical Care Facilities

Compare with peers Screen the whole industry

Company
APOLLOHOSPApollo Hospitals Enterprise	8,446.00	plus 0.90%	1,21,441	54.0	11.45	19.2%	22.5%	15.4%	14.8%	33.3%	0.24%	plus 7.2%
MAXHEALTHMax Healthcare Institute	934.00	plus 0.21%	90,909	66.1	8.03	12.6%	12.8%	26.8%	22.4%	9.3%	0.21%	minus 18.1%
MANIPALHOSManipal Health Enterprises	646.70	minus 1.61%	85,065	133.6	9.05	9.8%	9.2%	17.8%	–	–	0.00%	minus 3.0%
ASTERDMAster DM Quality Care	713.15	minus 0.89%	62,092	90.7	8.06	9.4%	9.7%	17.4%	15.7%	−3.0%	0.42%	plus 4.5%
FORTISFortis Healthcare	766.90	minus 6.45%	57,898	55.7	5.52	11.9%	10.4%	22.2%	13.3%	20.9%	0.13%	minus 19.6%
NHNarayana Hrudayalaya	1,903.00	minus 0.65%	38,650	44.7	7.73	11.4%	19.1%	18.5%	20.5%	9.9%	0.24%	plus 4.7%
MEDANTAGlobal Health	1,387.60	minus 0.15%	37,264	60.4	8.63	15.0%	15.2%	22.1%	17.2%	19.5%	0.04%	plus 11.2%
INDRAMEDCOIndraprastha Medical Corporation	330.20	minus 1.06%	3,027	16.1	3.72	30.3%	26.1%	18.3%	10.2%	28.7%	1.21%	minus 44.8%
Median of 7 peers	–	−0.65%	62,092	60.4	8.06	11.9%	12.8%	18.5%	16.5%	14.7%	0.21%	4.5%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Mar 25	Jun 25	Dec 25	Mar 26	Jun 26
334	365	372	365	406
–	–	–	+9.3%	+11.3%
272	292	310	304	326
61.3	73.2	62	60.5	79.8
18.4%	20.0%	16.7%	16.6%	19.7%
6.4	6.9	7.2	7.3	8.4
1.5	1.6	1.5	1.5	1.7
10.9	10.2	11.3	11.3	11.8
55.3	68.3	56.4	55	74.8
25.8%	24.7%	27.3%	24.2%	25.4%
41	51.5	41	41.7	55.9
–	–	–	+1.7%	+8.5%
4.47	5.61	4.47	4.55	6.09

Sep 25 not reported by the data source.

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +10.2%
Profit CAGR 3Y: +28.7%
EPS CAGR 3Y: +28.7%
ROE: 26.1%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
1,065	1,204	1,307	1,425
–	+13.1%	+8.5%	+9.0%
913	1,000	1,053	1,148
152	204	254	277
14.2%	17.0%	19.5%	19.4%
6.2	4.3	9.8	14.8
0.5	1.1	3	2.9
39.3	40.1	44.3	43.6
−0.9	−1.2	−0.5	0.6
117	166	216	246
26.5%	25.4%	25.6%	25.4%
86.2	124	161	184
–	+43.9%	+29.9%	+14.1%
9.40	13.52	17.56	20.03

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
91.7	91.7	91.7	91.7
288	386	505	649
2.5	34	32.8	36.9
173	212	222	214
555	723	852	991
281	349	361	369
7.2	3	33.2	4.1
47.4	60.5	54.9	201
133	228	328	271
86.2	82.6	75.2	147
555	723	852	991

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
144	200	157	167
−108	−158	−111	−178
−26	−32.4	−45.9	−46.4
10.5	9.3	−0.1	−56.6
−44.6	−69.4	−36.3	−59.7
99.9	131	120	108
−22.8	−27.5	−40.7	−41

Shareholding pattern

Source: NSE filings

51.0%

promoters

Promoters51.00%
Public49.00%
As of 30 Sep 2026

Quarter	Promoters	Public	Promoter change
30 Sep 2026	51.00%	49.00%	0.00
30 Jun 2026	51.00%	49.00%	0.00
31 Mar 2026	51.00%	49.00%	0.00
31 Dec 2025	51.00%	49.00%	0.00
30 Sep 2025	51.00%	49.00%	–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you